Abstract
Small-cell lung cancer is rarely cured with standard chemotherapy, despite initial good responses. The concept of high-dose induction therapy for extensive-stage patients has been explained in a series of pilot studies. The rationale of this approach and the most recent preliminary results will be presented.
Original language | English (US) |
---|---|
Pages (from-to) | 37-39 |
Number of pages | 3 |
Journal | Seminars in oncology |
Volume | 13 |
Issue number | 3 SUPPL. 3 |
State | Published - Sep 1986 |
ASJC Scopus subject areas
- Hematology
- Oncology